Stephanie Gaglione

Research Specialist Limited-MIT Doctoral

Department
David H Koch Institute for Integrative Cancer Res
Technology Areas
Biotechnology: DNA & RNA Editing, Synthetic Biology / Drug Delivery: Vectors & Virus like Particles / Therapeutics: Cell Based Therapy, Nucleic Acids
Impact Areas

Technologies

Specific Viral Targeting of Hematopoietic Stem Cells via Engineering of Viral Tropism

Exclusively Licensed Technology / Case number: #22988JQ
Michael Birnbaum / Cassandra Burnett / Kole Roybal / Stephanie Gaglione / Connor Dobson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.